Vorolanib is a multi-targeted tyrosine kinase inhibitor that functions as a potent dual blocker of vascular endothelial growth factor receptors and platelet-derived growth factor receptors. This small… Read more
Vorolanib is a multi-targeted tyrosine kinase inhibitor that functions as a potent dual blocker of vascular endothelial growth factor receptors and platelet-derived growth factor receptors. This small molecule is primarily employed in the treatment of advanced solid tumors and is under evaluation for various ophthalmic conditions characterized by pathological angiogenesis. To support the rigorous demands of pharmaceutical research and development, this category provides high-quality reference standards, including impurities, metabolites, and stable isotope labelled compounds. Laboratories utilize these materials for essential analytical testing, such as impurity profiling and method validation, ensuring precise quantification and regulatory compliance in drug substance analysis. The inclusion of stable isotope labelled variants is particularly valuable for LC-MS/MS assays, where they serve as reliable internal standards to enhance measurement accuracy and reproducibility during quality control procedures, facilitating the verification of drug purity and chemical integrity throughout the manufacturing lifecycle.